PMID: 9553806Apr 29, 1998Paper

Primary ovarian rhabdomyosarcoma: a report of 13 cases

International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
G P NielsenR E Scully

Abstract

Primary ovarian rhabdomyosarcomas were found in 13 patients aged 7 to 79 (mean 37) years who had reported abdominal pain and swelling. Six tumors involved the right ovary, 3 involved the left, 1 involved both, and the laterality was unknown in 3 cases. Four tumors were stage I, 2 were stage II, 4 were stage III, and 2 were stage IV; the stage of 1 tumor is not known. The tumors ranged from 10 to 19.5 (average 16) cm in diameter and had solid sectioned surfaces that varied from yellow to white to pink and from gelatinous to hemorrhagic. Microscopically, 11 tumors were embryonal and 2 were alveolar rhabdomyosarcomas. Follow-up information, available for 11 patients, revealed that 7 died of disease 10 days to 26 months postoperatively; 2 of these patients had stage II disease, 3 had stage III, and 2 had stage IV. Four patients were alive 2 to 9 months postoperatively; 3 had stage I and 1 had stage III disease. These 13 tumors and an additional 10 from the English-language literature are reviewed and the differential diagnosis of ovarian rhabdomyosarcoma is discussed.

Citations

Nov 16, 2007·Pediatric Surgery International·Randolph K CribbsRichard R Ricketts
Sep 14, 2000·The Urologic Clinics of North America·M Kaefer, R C Rink
Apr 11, 2001·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·G P Nielsen, R H Young
Jan 10, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Hiroyuki YanaiTadashi Yoshino
Jun 27, 2008·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Daniela S Allende, Bin Yang
Jun 2, 2009·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Mehmet KefeliArif Kokcu
Feb 23, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Oluwole FadareVinita Parkash
Apr 22, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Roberto TiraboscoAdrienne M Flanagan
Jan 1, 2011·BMJ Case Reports·Asim QureshiRakshanda Rehman
Dec 3, 2014·Seminars in Diagnostic Pathology·Robert H Young
Oct 14, 2011·Advances in Anatomic Pathology·Carmen Bárcena, Esther Oliva
Aug 25, 2007·Advances in Anatomic Pathology·Julie A Irving, W Glenn McCluggage
Jan 29, 2020·The American Journal of Surgical Pathology·W Glenn McCluggageWilliam D Foulkes
Mar 24, 2018·Indian Journal of Pathology & Microbiology·Ilavarasi VanidassaneSameer Rastogi
Jul 14, 2020·The Journal of Obstetrics and Gynaecology Research·Fatma Öz AtalayÖnder Bozdogan
Mar 12, 2015·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Sharon X LiangKarin Shih
Oct 30, 1998·Ultrastructural Pathology·G R Dickersin, R E Scully
May 22, 2021·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jennifer A BennettEsther Oliva
Dec 1, 2009·Surgical Pathology Clinics·Koen K Van de Vijver, Esther Oliva
Dec 1, 2009·Surgical Pathology Clinics·Cheng-Han LeeC Blake Gilks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.